Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus

Table 3

Various parameters associated with the efficacy of tofogliflozin in univariate analyses.

Comparison	ρ
Baseline HbA1c versus Δ HbA1c (4 w)	0.614	<0.01
Baseline HbA1c versus Δ HbA1c (12 w)	0.630	<0.01
Baseline VFA versus Δ HbA1c (4 w)	−0.169	<0.01
Baseline VFA versus Δ HbA1c (12 w)	−0.019	<0.01
Δ VFA (4 w) versus Δ HbA1c (4 w)	0.371	<0.05
Δ VFA (12 w) versus Δ HbA1c (12 w)	0.177	n.s.
Baseline VFA versus Δ VFA (4 w)	0.993	<0.01
Baseline VFA versus Δ VFA (12 w)	0.002	n.s.